相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。T cells in multiple sclerosis and experimental autoimmune encephalomyelitis
J. M. Fletcher et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis
Monica Marta et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis
E. Butti et al.
GENE THERAPY (2008)
Type 1 interferons cool the inflamed brain
Robert C. Axtell et al.
IMMUNITY (2008)
Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system
Marco Prinz et al.
IMMUNITY (2008)
The type IIFN induction pathway constrains Th17-mediated autoimmune inflammation in mice
Beichu Guo et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage
Lawrence Steinman
NATURE MEDICINE (2007)
Lipopolysaccharide pretreatment modulates the disease course in experimental autoimmune encephalomyelitis
Abigail C. Buenafe et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Natural regulatory T cells: mechanisms of suppression
Makoto Miyara et al.
TRENDS IN MOLECULAR MEDICINE (2007)
HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice
R. Furlan et al.
GENE THERAPY (2007)
Cutting edge:: TLR3 stimulation suppresses experimental autoimmune encephalomyelitis by inducing endogenous IFN-β
Tarik Touil et al.
JOURNAL OF IMMUNOLOGY (2006)
Th2 cytokines down-regulate TLR expression and function in human intestinal epithelial cells
Tobias Mueller et al.
JOURNAL OF IMMUNOLOGY (2006)
Enhancement of Th2 responses to replicative herpes simplex virus type 1 vectors by immunomodulative chemotherapy
J Peltoniemi et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2006)
Glatiramer acetate reduces lymphocyte proliferation and enhances IL-5 and IL-13 production through modulation of monocyte-derived dendritic cells in multiple sclerosis
A Sanna et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis
M Prinz et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
H Park et al.
NATURE IMMUNOLOGY (2005)
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages
LE Harrington et al.
NATURE IMMUNOLOGY (2005)
Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis
HH Hofstetter et al.
CELLULAR IMMUNOLOGY (2005)
HSV trafficking and development of gene therapy vectors with applications in the nervous system
AR Frampton et al.
GENE THERAPY (2005)
Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self
S Sakaguchi
NATURE IMMUNOLOGY (2005)
Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease
KS Lang et al.
NATURE MEDICINE (2005)
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
CL Langrish et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Immunomodulation by roquinimex decreases the expression of IL-23 (p19) mRNA in the brains of herpes simplex virus type 1 infected BALB/c mice
J Peltoniemi et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Spread and replication of and immune response to γ134.5-negative herpes simplex virus type 1 vectors in BALB/c mice
EK Broberg et al.
JOURNAL OF VIROLOGY (2004)
IL-4 is the key regulator in herpes simplex virus-based gene therapy of BALB/c experimental autoimmune encephalomyelitis
EK Broberg et al.
NEUROSCIENCE LETTERS (2004)
Naturally arising CD4(+) regulatory T cells for immunologic self-tolerance and negative control of immune responses
S Sakaguchi
ANNUAL REVIEW OF IMMUNOLOGY (2004)
IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis
B Becher et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Correlation of serum IL-13 and IL-5 levels with clinical response to Glatiramer acetate in patients with multiple sclerosis
E Wiesemann et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
IFN-β gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis
I Teige et al.
JOURNAL OF IMMUNOLOGY (2003)
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
DJ Cua et al.
NATURE (2003)
IL-5-deficient mice are susceptible to experimental autoimmune encephalomyelitis
C Weir et al.
INTERNATIONAL IMMUNOLOGY (2003)
Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12
B Becher et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Herpes simplex virus type I infection induces upregulation of interleukin-23 (p19) rnRNA expression in trigeminal ganglia of BALB/c mice
EK Broberg et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2002)
Glatiramer acetate (GA) induces IL-13/Il-5 secretion in naive T cells
E Wiesemann et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Expression of interleukin-4 but not of interleukin-10 from a replicative herpes simplex virus type 1 viral vector precludes experimental allergic encephalomyelitis
E Broberg et al.
GENE THERAPY (2001)
Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice
R Furlan et al.
GENE THERAPY (2001)
CPG oligonucleotides are potent adjuvants for the activation of autoreactive encephalitogenic T cells in vivo
BM Segal et al.
JOURNAL OF IMMUNOLOGY (2000)
Anti-IL-12 antibody prevents the development and progression of multiple sclerosis-like relapsing-remitting demyelinating disease in NOD mice induced with myelin oligodendrocyte glycoprotein peptide
M Ichikawa et al.
JOURNAL OF NEUROIMMUNOLOGY (2000)
分享论文
